#
Title
1

Subclinical Primary Aldosteronism and eGFR Decline

2

ASN Kidney Translation Series: Peritoneal Dialysis

3

PD Use in Health Service Areas, 2009–2020

4

ASN Kidney Translation Series: ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure

5

LCN2-Induced CLUH Inhibition Disrupts Mitochondria in Kidney

6

ASN Kidney Translation Series: Kidney Transplant Advances

7

Automatic Organ and Cyst Volumes in ADPKD

8

Coronary Disease Screening Prior to Kidney Transplant

9

ASN Kidney Translation Series: Advances in Glomerular Filtration Rate

10

Bone Marrow Inflammation Drives Glomerular Damage

11

ICD Code Accuracy for CVD in CKD

12

Dapagliflozin and HRQoL in Patients with CKD

13

ASN Kidney Translation Series: Glomerulonephritis

14

ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives

15

RNA Sequencing of IgA Nephropathy Kidneys

16

Alternative Splicing and Polyadenylation in Glomerular Disease

17

ASN Kidney Translation Series: Cardiovascular-Kidney Connection

18

The PEER-HD Randomized Controlled Trial

19

Disaster Management in Kidney Care

20

Regulation of Renal Glucose Handling by mTORC2

21

Drug Screening in Drosophila Nephrocytes

22

ASN Kidney Translation Series: ADPKD Advances

23

Anticoagulation in Dialysis Recipients with Atrial Fibrillation

24

CASR Determines Renal Response to Hypercalcemia

25

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury

26

ASN Kidney Translation Series: Kidney Stones

27

Molecular Signature of NPCs in the Catshark

28

Acetazolamide and the Kidney in T1D

29

Kidney Protection by Acetylcholine

30

ASN Kidney Translation Series: Genetic Testing in Nephrology

31

JASN Welcomes Basic Science Research

32

ASN Kidney Translation Series: Novel Therapies for IgA Nephropathy

33

Polycystin-2 Regulates Natriuretic Peptide Production

34

ASN Kidney Translation Series: ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

35

KLF15 Agonist in Kidney Disease

36

Stem Cells in Renovascular Disease

37

ASN Kidney Translation Series: Gender Equity in Nephrology

38

Complications of Uninephrectomy

39

JASN Welcomes Late-Breaking Clinical Trial Manuscript Submissions

40

sGC Activator Avenciguat for CKD

41

Absolute CKD Progression Risk

42

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury

43

Tubular Effect of Proteinuria

44

Set7 Regulates Glomerular Injury

45

Daprodustat and Heart Failure in CKD

46

Changes in ESKD Incidence

47

Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN

48

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

49

Kidney Transplant Registry Data: Advice for Users

50

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

51

Historical Redlining and the Incidence of Kidney Failure in US Cities

52

Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD

53

How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters

54

The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury

55

Urea and Uremia

56

Genomic Diagnostic Methods for CKD

57

Intensive BP Control and CKD Progression and Prognosis in Anti-GBM Disease

58

Pregnancy Risk for Kidney Patients; Cost Effectiveness Research in Dialysis

59

Use of Kidney Organoids to Study Steroid-Resistant Nephrotic Syndrome

60

Highlights in Renal Transplantation

61

Comparing Costs of Hemodialysis and Peritoneal Dialysis

62

Gender Differences in Care of CKD Patients

63

Climate Change: Implications for Nephrology

64

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

65

Addressing Racial and Ethnic Disparities in Kidney Disease

66

Discontinuing Immunosuppressant Use after Allograft Failure: Do We Have the Answers?

67

A New Approach to Advance Care Planning for Dialysis Decisions: Deciding not to Decide

68

JASN May 2022 Highlights: Inflammation as a Driver of CKD Progression

69

Roxadustat and the Interpretation of Non-Inferiority

70

The Renal Framingham - CVD Prediction

71

Lowering GFR to Protect GFR!

72

Insights into Collapsing Glomerulopathy

73

The Immune Responses to COVID-19 in Transplant Patients

74

JASN November 2021 Issue Highlights

75

JASN October 2021 Issue Highlights

76

New Directions for Clinical Trials in Kidney Disease

77

JASN August 2021 Issue Highlights

78

Lost Opportunities for Kidney Transplant

79

The Extracellular Matrix in Development, Aging, and Disease

80

Vaccine Acceptability and Hemodialysis Patients

81

COVID-19 Mortality and the Tough Discussions about Advance Care Planning

82

New Insights into the Mechanisms of Kidney Disease: Understanding Hypercholesterolemia in CKD; ADAM10 and Immune Injury to the Podocyte Slit Diaphragm

83

JASN May 2022 Issue Highlights

84

JASN April 2021 Issue Highlights

85

JASN March 2021 Issue Highlights

86

JASN February 2021 Issue Highlights

87

JASN January 2021 Issue Highlights

88

A Conversation with Mark Knepper and Josie Briggs: Does SARS-CoV2 Infect the Kidney?

89

A Dialogue with Mahboob Rahman and Erin Barreto About Ambulatory Blood Pressure Monitoring in Patients with Chronic Kidney Disease

90

A Discussion with Andrew Malone and Madhav Menon: RNAseq and the Transplant Biopsy, What is New?

91

A Conversation with Deidre Crews and Tanjala Purnell about COVID-19, Structural Racism and Kidney Disease